CONCLUSIONS The authors did not observe a survival advantage with local therapy in addition to standard androgen deprivation therapy for men with metastatic prostate cancer. However, the results of the current study did affirm advantages in the setting of locally advanced disease. Aggressive local ...
and it disproportionally affects Black men, who are twice as likely to be diagnosed with and die of the disease. Catching this cancer in its early stages is key, as the five-year survival rate for an early-stage prostate cancer diagnosis is 98%, versus 31% for later-stage diag...
formulated by Aparicio et al.: 1) Histological evidence of small cell neuroendocrine prostate cancer (NEPC); 2) presence of exclusively visceral metastases; 3) predominant lytic bone metastases; 4) bulky lymphadenopathy or bulky high-grade
Prostate Cancer: Prostate cancer is cancer that begins in the prostate gland, which is part of the male reproductive system. While most prostate cancers are slow growing, recent studies have indicated that the more aggressive forms of prostate cancer may be on the rise. ...
Prostate cancer (PCa) is the most commonly diagnosed genital cancer in men worldwide. Around 80% of the patients who developed advanced PCa suffered from bone metastasis, with a sharp drop in the survival rate. Despite great efforts, the detailed mechanisms underlying castration-resistant PCa (CRP...
The cellular shapeshifting causes neuroendocrine prostate cancer to develop in 15% of patients receiving androgen receptor therapy. This makes NEPC the second-most common type of this disease. And it's especially deadly: The median survival rate of someone with neuroendocrine prostate cancer is only ...
Survivin is an Inhibitor of Apoptosis Protein (IAP), which makes it responsible for cell proliferation and survival by inhibiting regulated cell death and promoting mitosis. The exact role that it plays in prostate cancer is not yet full... B Mr.,J Brandon - 《Mcnair Scholars Research Journal...
Prostate cancer is one of the most common cancers in men, and has one of the highest five-year survival rates when diagnosed in the localised stage. When diagnosed in the advanced stage or when a localised tumour relapses after the initial localtreatment, the usual procedure is to fight it...
How aggressive is esophageal cancer? Is rectal cancer the same as colorectal cancer? What is the survival rate of metastatic colorectal cancer? What are risk factors for colorectal cancer? How common is anal cancer? Is bowel cancer and colorectal cancer the same?
More than half of the cases of breast cancer can be anticipated to exhibit recurrent disease. Most deaths occur within five years of discovery. There has been a minimum reduction in the mortality rate in the past 35 years. This failure is due to microemboli that spread via both the ...